Authorising Engineer (MD): a vital new role

Hospitals globally face persistent challenges in medical device management, impacting patient safety, operational efficiency, and financial sustainability. This paper draws insights from a seminal doctoral case study conducted within an NHS Trust, which explored the transformative potential of a collaborative, expert-led intervention in medical device management policy. The study identified systemic issues such as fragmented procurement, inconsistent training, and siloed departmental operations, directly contributing to avoidable patient harm and escalating costs.

Findings demonstrate that an independent, expert-driven approach, analogous to the role of an Authorising Engineer (Medical Devices) (AE (MD)), can effectively identify latent risks, drive comprehensive policy redesign, and foster a culture of continuous improvement. This leads to significant benefits including substantial cost savings, enhanced patient safety, improved staff competency, and strengthened clinical governance, thereby positioning the AE (MD) as a vital strategic asset for NHS Trusts in an increasingly complex regulatory and technological landscape.

Medical devices are foundational to contemporary healthcare delivery, underpinning diagnostics, therapeutic interventions, and patient rehabilitation. However, their escalating volume, diversity, and technological complexity present formidable management challenges for healthcare organisations globally. Reputable international and national bodies, including the National Audit Office (NAO), National Patient Safety Agency (NPSA), Medicines and Healthcare products Regulatory Agency (MHRA), NHS Resolution (formerly NHS Litigation Authority), and the World Health Organization (WHO), have consistently documented critical issues stemming from suboptimal medical device management. These issues directly impact patient safety and contribute significantly to escalating healthcare costs.